Factors accounting for asthma variability: Achieving optimal symptom control for individual patients

Primary Care Respiratory Journal

Volumn 17, Issue 3, 2008, Pages 138-147

  Yawn, Barbara P ^a,b  

^a OLMSTED MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Asthma; Control; Environment; Symptoms; Treatment; Treatment plans; Variability

Indexed keywords

ACETYLSALICYLIC ACID; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CIGARETTE SMOKE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; SALSALATE;

AIR POLLUTANT; ALLERGIC RHINITIS; ASTHMA; COMORBIDITY; DISEASE CONTROL; DISEASE EXACERBATION; ENVIRONMENTAL FACTOR; EXERCISE; HEALTH PROGRAM; HUMAN; PREGNANCY; PROPHYLAXIS; REVIEW; SEASONAL VARIATION; TREATMENT PLANNING;

ASTHMA; COMORBIDITY; ENVIRONMENT; HUMANS; NEBULIZERS AND VAPORIZERS; PATIENT CARE PLANNING; SELF CARE; SEVERITY OF ILLNESS INDEX;

EID: 51349161037     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.3132/pcrj.2008.00004     Document Type: Review

References (69)

1. National Center for Health Statistics. Health, United States, 2005 With Chartbook on Trends in the Health of Americans. Hyattsville, Maryland: 2005.
2. Sly RM. Continuing decreases in asthma mortality in the United States. Ann Allergy Asthma Immunol 2004;92:313-18.
3. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Updated 2005. Available at URL http://www.ginasthma. org accessed 10.01.2006.
4. EPR-Update 2007. Expert Panel Report 3 (EPR 3): Guidelines for the diagnosis and management of asthma. NIH Prepublications copy No. 08-4051. Bethesda, MD: US Department of Health and Human Services: National Institutes of Health; National Heart, Lung, and Blood Institute: National Asthma Education and Prevention Program, August 2007. Available at http://www.nhlbi. nih.gov/guidelines/asthma/asthgdln.htm.
5. Adams RJ, Fuhlbrigge A, Guilbert T, Lozano P, Martinez F. Inadequate use of asthma medication in the United States: results of the asthma in America national population survey. J Allergy Clin Immunol 2002;110:58-64.
6. Calhoun WJ, Sutton LB, Emmett A, Dorinsky PM. Asthma variability in patients previously treated with β,2-agonists alone. J Allergy Clin Immunol 2003; 112:1088-94.
7. Vollmer WM. Assessment of asthma control and severity. Ann Allergy Asthma Immunol 2004;93:409-13.
8. Yawn BP, Yawn RA. Measuring asthma quality in primary care: can we develop better measures? Respir Med 2006;100:26-33.
9. Levy ML Robb M Allen J Doherty C Bland JM Winter RJ. A randomised controlled evaluation of specialist nurse education following accident and emergency department attendance for acute asthma. Respir Med 2000; 94(9):900-08.
10. Reddel HK. The benefit of experience: patient perception of asthma self-management. Prim Care Resp J 2007;16(2):68-70. doi:10.3132/pcrj.2007.00022
11. McDonald VM, Gibson PG. Asthma self-management education. Chron Respir Dis 2006;3(1):29-37.
12. Charlton I. Evaluation of peak flow and symptoms only self-management plans for control of asthma in general practice. BMJ 1990; 301(6765):1355-9.
13. Silverman RA, Stevenson L, Hastings HM. Age-related seasonal patterns of emergency department visits for acute asthma in an urban environment. Ann Emerg Med 2003;42:577-86.
14. Weiss KB. Seasonal trends in US asthma hospitalizations and mortality. JAMA 1990;263:2323-8.
15. Riccioni G, Di Stefano F, De Benedictis M, et al. Seasonal variability of nonspecific bronchial responsiveness in asthmatic patients with allergy to house dust mites. Allergy Asthma Proc 2001;22:5-9.
16. Dharmage S, Bailey M, Raven J, et al. Mouldy houses influence symptoms of asthma among atopic individuals. Clin Exp Allergy 2002;32:714-20.
17. Partridge MR. Written asthma action plans. Thorax 2004;59(2):87-8.
18. Gibson P. Written action plans for asthma: an evidence-based review of the key components. Thorax 2004;59:94-9.
19. Hylkema MN, Sterk PJ, de Boer WI, Postma DS. Tobacco use in relation to COPD and asthma. Eur Respir J 2007;29(3):438-45.
20. Wark PA, Gibson PG. Asthma exacerbations 3: Pathogenesis. Thorax 2006; 61(10):909-15.
21. Schwartz J, Timonen KL, Pekkanen J. Respiratory effects of environmental tobacco smoke in a panel study of asthmatic and symptomatic children. Am J Respir Crit Care Med 2000;161(3 Pt 1):802-06.
22. Just J, Segala C, Sahraoui F, Priol G, Grimfeld A, Neukirch F. Short-term health effects of particulate and photochemical air pollution in asthmatic children. Eur Respir J 2002;20:899-906.
23. Rabinovitch N, Strand M, Gelfand EW. Particulate levels are associated with early asthma worsening in children with persistent disease. Am J Respir Crit Care Med 2006;173:1054-5.
24. Plaza V, Serrano J, Picado C, Sanchis J; High Risk Asthma Research Group. Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma. Eur Respir J 2002;19:846-52.
25. Korhonen K, Reijonen TM, Remes K, Malmstrom K, Klaukka T, Korppi M. Reasons for and costs of hospitalization for pediatric asthma: a prospective 1-year follow-up in a population-based setting. Pediatr Allergy Immunol 2001;12:331-8.
26. Sturdy PM, Victor CR, Anderson HR, et al. Psychological, social and health behaviour risk factors for deaths certified as asthma: a national case-control study. Thorax 2002;57:1034-9.
27. Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(Suppl):S147-334.
28. Antonicelli L, Micucci C, Voltolini S, et al. Allergic rhinitis and asthma comorbidity: ARIA classification of rhinitis does not correlate with the prevalence of asthma. Clin Exp Allergy 2007;37(6):954-60.
29. Calhoun WJ. Nocturnal asthma. Chest 2003;123(Suppl):399S- 405S.
30. Gibson PG, Henry RL, Coughlan JL. Gastro-oesophageal reflux treatment for asthma in adults and children. Cochrane Database Syst Rev 2003 (2) doi:10.1002/14651858.CD001496.
31. Chinese GERD Study Group. Value of reflux diagnostic questionnaire in the diagnosis of gastroesophageal reflux disease. Chin J Dig Dis 2004;5:51-5.
32. Shore SA, Fredberg JJ. Obesity, smooth muscle, and airway hyperresponsiveness. J Allergy Clin Immunol 2005;115:925-7.
33. Hakala K, Stenius-Aarniala B, Sovijärvi A. Effects of weight loss on peak flow variability, airways obstruction, and lung volumes in obese patients with asthma. Chest 2000;118:1315-21.
34. Tan KS. Premenstrual asthma: epidemiology, pathogenesis and treatment. Drugs 2001;61(14):2079-86.
35. Vrieze A, Postma DS, Kerstjens HA. Perimenstrual asthma: a syndrome without known cause or cure. J Allergy Clin Immunol 2003;112(2): 271-82.
36. Hanley SP. Asthma variation with menstruation. Br J Dis Chest 1981;75:306-08.
37. Yawn BP. Asthma in women: the hormonal link. Female Patient 2003;28:34-41.
38. Svanes C, Real FG, Gislason T, Jansson C, Jogi R, Norrman E, Nystrom L, Toren K, Omenaas E. Association of asthma and hay fever with irregular menstruation. Thorax 2005;60(6):445-50.
39. Adams RJ, Wilson DH, Taylor AW, et al. Coexistent chronic conditions and asthma quality of life: a population-based study. Chest 2006;129:285-91.
40. Blackburn D, Hux J, Mamdani M. Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly. J Gen Intern Med 2002;17:717-20.
41. Anderson SD. Single-dose agents in the prevention of exercise-induced asthma: a descriptive review. Respir Med 2004;3:365-79.
42. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004;328:434-40.
43. Covar RA, Macomber BA, Szefler SJ. Medications as asthma triggers. Immunol Allergy Clin North Am 2005;25:169-90.
44. Schmaling KB, McKnight PE, Afari N. A prospective study of the relationship of mood and stress to pulmonary function among patients with asthma. J Asthma 2002;39:501-10.
45. Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma control study. Am J Respir Crit Care Med 2004;170:836-44.
46. Yawn B. Participatory research in rural primary care. Minn Med 2004;87:52-4.
47. Williams LK, Pladevall M, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 2004;114:1288-93.
48. Bhogal S, Zemek R, Ducharme FM . Written action plans for asthma in children. Art. No.: CD005306. DOI: 10,1002/14651858.CD005306.pub2.
49. Yawn B. Comparison of once-daily intranasal corticosteroids for the treatment of allergic rhinitis: are they all the same? MedGenMed 2006;8(1):23.
50. Corren J, Manning BE, Thompson SF, Hennessy S, Strom BL. Rhinitis therapy and the prevention of hospital care for asthma: a case-control study. J Allergy Clin Immunol 2004;113:415-19.
51. Aaron SD, Fergusson D, Dent R, Chen Y, Vandemheen KL, Dales RE. Effect of weight reduction on respiratory function and airway reactivity in obese women. Chest 2004;125:2046-52.
52. Gluck JC, Gluck PA. Asthma controller therapy during pregnancy. Am J Obstet Gynecol 2005;192:36-80.
53. National Heart, Lung, and Blood Institute; National Asthma Education and Prevention Program Asthma and Pregnancy Working Group. NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment - 2004 update. J Allergy Clin Immunol 2005;115:34-46.
54. Murphy VE, Gibson PI, Talbot CG, Kessell G, Clifton VL. Asthma self-management skills and the use of asthma education during pregnancy. Eur Respir J 2005;26(3):435-41.
55. Chambers CV, Markson L, Diamond JJ, Lasch L, Berger M. Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices. Respir Med 1999;93:88-94.
56. Clark NM, Gong M, Schork MA, et al. Long-term effects of asthma education for physicians on patient satisfaction and use of health services. Eur Respir J 2000;16:15-21.
57. Onyirimba F, Apter A, Reisine S, et al. Direct clinician-to-patient feedback discussion of inhaled steroid use: its effect on adherence. Ann Allergy Asthma Immunol 2003;90:411-15.
58. Gibson PG, Powell H, Coughlan J, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2002 (3) doi:10.1002/14651858.CD001117.
59. Ring N, Malcolm C, Wyke S, et al. Promoting the use of Personal Asthma Action Plans: a systematic review. Prim Care Resp J 2007;16(5):271-83. doi:10.3132/pcrj.2007.00049
60. Yawn BP, Brenneman SK, Allen-Ramey FC, Cabana MD, Markson LE. Assessment of Asthma Severity and Asthma Control in Children. Pediatrics 2006;118(1):322-9.
61. Vollmer WM. Assessment of asthma control and severity. Ann Allergy Asthma Immunol 2004;93:409-13.
62. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004;113:59-65.
63. QualityMetrics, Inc. Childhood Asthma Control Test for children with asthma 4 to 11 years old. http://www.asthmacontrol.com/AsthmaControlTestChild. html. 2005. GlaxoSmithKline, Inc.
64. Lenoir M, Williamson A, Stanford RH, Stempel DA Assessment of asthma control in a general population of asthmatics. Curr Med Res Opin 2006; 22(1):17-22.
65. Vollmer WM, Markson LE, O'Connor E, et al. Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med 1999;160:1647-52.
66. Vollmer WM, Markson LE, O'Connor E, Frazier EA, Berger M, Buist AS. Association of asthma control with health care utilization: a prospective evaluation. Am J Respir Crit Care Med 2002;165:195-9.
67. Skinner EA, Diette GB, Algatt-Bergstrom PJ, et al. The Asthma Therapy Assessment Questionnaire (ATAQ) for children and adolescents. Dis Manag 2004;7:305-13.
68. Narayanan S, Edelman JM, Berger ML, Markson LE. Asthma control and patient satisfaction among early pediatric users of montelukast. J Asthma 2002;39:757-65.
69. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14:902-07.